
Loading, please wait...

Loading, please wait...

Recent research highlights the necessity of rhythm control in FAMR (atrial functional mitral regurgitation) for patients with heart failure with preserved ejection fraction (HFpEF). While mitral regurgitation often accompanies heart failure, atrial fibrillation (AF) significantly complicates the clinical trajectory. Researchers analyzed 218 patients to see how AF affects regurgitation severity and outcomes. Their findings underscore a vital shift in how clinicians should manage these comorbid conditions.
The study revealed a stark contrast between patients in sinus rhythm and those with AF. Specifically, moderate FAMR occurred in 53.3% of AF patients but only 24.5% of those in sinus rhythm. Furthermore, severe FAMR was nearly twice as common in the AF group. Consequently, atrial fibrillation seems to drive significant valve dysfunction within the HFpEF population by promoting atrial remodeling and annular dilation.
Clinical outcomes significantly worsened for AF patients with severe FAMR. These individuals faced a 4.1-fold higher risk of heart failure hospitalization. Moreover, the risk for the composite endpoint, including cardiovascular death, rose by 2.6 times. In contrast, regurgitation severity did not significantly predict outcomes for patients maintaining a normal sinus rhythm. These data suggest that the combination of AF and FAMR creates a high-risk phenotype that requires targeted intervention.
Clinicians should therefore prioritize rhythm control in FAMR as a core pathogenetic strategy. Restoring sinus rhythm may halt left atrial remodeling and reverse annular dilation. This approach could significantly lower the heavy burden of hospitalizations observed in this patient category. Overall, managing the underlying arrhythmia is just as important as treating the heart failure symptoms themselves to improve long-term survival.
FAMR is a type of heart valve dysfunction where the mitral valve leaks due to atrial enlargement and annular dilation. It typically occurs in patients with atrial fibrillation despite having a preserved left ventricular ejection fraction.
Maintaining sinus rhythm helps reduce the severity of mitral regurgitation. Research shows it specifically lowers the risk of heart failure rehospitalization, which is significantly elevated when AF and severe regurgitation coexist.
Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or a substitute for professional healthcare. Always consult a qualified physician for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Study confirms that rhythm control in FAMR is essential for HFpEF patients, as AF-linked severe regurgitation 4.1x increases heart failure hospitalization....
5 months ago

With Telangana registering a 125-fold rise in leptospirosis cases and several Indian states reporting monsoon spikes, clinicians face major diagnostic challenges. This article details the clinical spectrum, transmission dynamics, diagnostic protocols, and antimicrobial strategies to differentiate it from dengue.
Today

A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
Today

A systematic review and meta-analysis of 21 RCTs reveals that exercise snacks significantly improve VO2max and peak power output in adults. While aerobic gains were strongest in adults under 50, power output improved across all ages. Evidence for blood lipids and body fat changes remains inconsistent.
Today

A ten-year review highlights how preclinical time-lapse micro-CT and synchrotron imaging allow dynamic tracking of cortical bone porosity and remodeling space kinetics. Recent studies reveal how therapeutic agents like PTH and glucocorticoids alter linear erosion rates and pore morphology.
Today

A study demonstrates that gomisin N (25 µM) protects MIN6 pancreatic beta-cells by alleviating endoplasmic reticulum and oxidative stress induced by CPA. By reducing ROS levels and promoting correct proinsulin folding, gomisin N restores insulin secretion and beta-cell viability in diabetes models.
Today